Comprehensive exams for Mental Health Q 151



Nurse Daisy is aware that the following pharmacologic agents are sedative-hypnotic medication is used to induce sleep for a client experiencing a sleep disorder is:
  
     A. triazolam (Halcion)
     B. paroxetine (Paxil)
     C. fluoxetine (Prozac)
     D. risperidone (Risperdal)
    
    

Correct Answer: A. triazolam (Halcion)

Triazolam is one of a group of sedative-hypnotic medications that can be used for a limited time because of the risk of dependence. Triazolam is used on a short-term basis to treat insomnia (difficulty falling asleep or staying asleep). Triazolam is in a class of medications called benzodiazepines. It works by slowing activity in the brain to allow sleep. Triazolam comes as a tablet to take by mouth. It is usually taken as needed at bedtime but not with or shortly after a meal. Triazolam may not work well if it is taken with food.

Option B: Paroxetine is a serotonin-specific reuptake inhibitor used for treatment of depression, panic disorder, and obsessive-compulsive disorder. It is FDA approved for major depressive disorder (MDD), obsessive-compulsive disorder (OCD), social anxiety disorder (SAD), panic disorder, posttraumatic stress disorder (PTSD), generalized anxiety disorder (GAD), and premenstrual dysphoric disorder (PMDD), vasomotor symptoms associated with menopause.
Option C: Fluoxetine is a serotonin-specific reuptake inhibitor used for depressive disorders and obsessive-compulsive disorders. Fluoxetine has FDA-approval for major depressive disorder (age eight and older), obsessive-compulsive disorder (age seven and older), panic disorder, bulimia, binge eating disorder, premenstrual dysphoric disorder, bipolar depression (as an adjunct with olanzapine also known as Symbyax), and treatment-resistant depression when used in combination with olanzapine.
Option D: Risperidone is indicated for psychotic disorders. The long-acting risperidone injection has been approved for the use of schizophrenia and maintenance of bipolar disorder (as monotherapy or adjunctive to valproate or lithium) in adults. Risperidone has also been used for augmentation of antidepressant therapy in the treatment of non-psychotic unipolar depression. In addition to irritability associated with autism, risperidone has also been used for social impairment, stereotypical behaviors, cognitive problems, and hyperactivity in autism.